JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2012, 61(4):163-168

Magistral prepared lidocaine-gel for topical aplication on skin

Zbyněk Sklenář1,*, Kateřina Horáčková2, Hana Bakhouche1, Ondřej Slanař1
1 Farmakologický ústav 1. lékařské fakulty UK, Česká republika
2 Lékárna Na Rohožníku, Praha

Due to a limited availability of industrially manufactured products containing local anesthetics for skin application and an increased demand for lidocaine-containing gel applicable prior to a product containing capsaicin for neuropathic pain treatment, it is necessary to prepare a topical semi-solid preparation containing the local anesthetic in pharmacies. Our aim was to create a mixed system of a hydrophilic gel with the emulsified drug, using excipients to decrease the lidocaine melting point, thereby creating a eutectic mixture with a high concentration of lidocaine in the oil phase. Based on bibliographic data, thymol creating a binary eutectic system containing lidocaine has been chosen. After addition of other excipients, an emulsion system was prepared and the drug was stabilized in the oil phase by a mixed nonionic emulsifier and carbomera. For the optimal anesthetic effects, the pH value should be adjusted; trometamol has been chosen as a suitable basic reacting excipient. Based on the addition of different amounts of trometamol, pH values of individual emulgels have been measured and the final composition of lidocaine emulgel has been created. A recipe for a 5 % lidocaine emulgel with the pH value of 9.1 has been created, based on the gel-forming substance carbomera with an emulsion of the oil phase containing a eutectic mixture of lidocaine and thymol, with an addition of ethanol and propylenglycol, stabilized by a mixed nonionic emulsifier. The advantage is the absence of other local anesthetics.

Keywords: lidocaine emulgel; binary eutectic mixture; compounded (magistral) preparation; capsaicin 8% patch; thymol; occlusive dressing

Received: May 11, 2012; Accepted: July 18, 2012; Published: April 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Sklenář Z, Horáčková K, Bakhouche H, Slanař O. Magistral prepared lidocaine-gel for topical aplication on skin. Čes. slov. farm. 2012;61(4):163-168.
Download citation

References

  1. Kang L., Jun H. W., Mani N. Preparation and characterization of two-phase melt systems of lidocaine. Int J Pharm 2001; 222, 35-44. Go to original source... Go to PubMed...
  2. Státní ústav pro kontrolu léčiv, databáze léků. Dostupné z: http://www.sukl.cz/modules/medication/search.php (15. 2. 2012).
  3. Astellas Pharma Europe B. V. Souhrn údajů o přípravku Qutenza náplast. 10-2009. Dostupné z: http://www.ema.europa.eu/docs/cs_CZ/document_library/EPAR_Product_Information/human/000909/WC500040453.pdf (15. 11. 2011).
  4. Kaweski S. Topical anesthetic creams. Plast Reconstr Surg 2008; 121, 2161-2165. Go to original source... Go to PubMed...
  5. Kang L., Jun H. W., McCall, J. W. Physicochemical studies of lidocaine-menthol binary systems for enhanced membrane transport. Int J Pharm 2000; 206, 35-42. Go to original source... Go to PubMed...
  6. Rezepturhinweise: Lidocain zur Anwendung auf der Haut. 2-2011. Dostupné z: http://www.pharmazeutische-zeitung.de/fileadmin/nrf/pdf/1-Lidocain_Haut.pdf (15. 8. 2011).
  7. Deutscher Arzneimittel-Codex (DAC) 2011/Neues Rezeptur-Formularium (NRF). Band I-III. Eschborn, Govi-Verlag und Stuttgart: Deutscher Apotheker-Verlag, 2011.
  8. Wynn R. L., Meiller T. F., Crossley H. L. Drug information handbook for dentistry. 15. ed. Hudson, Ohio: Lexi-Comp 2009; 1038-1040.
  9. Nortier Y. L., van de Haven J. A., Koks C. H., Beijnen J. H. Preparation an stability testing of a hydrogel for topical analgesia. Pharm. World Sci. 1995; 17, 214-217. Go to original source... Go to PubMed...
  10. Český lékopis 2009, Doplněk 2010. [CD-ROM]. 1. vyd. Praha: Grada Publishing, a.s. 2010.
  11. Rezepturhinweise: Lidocain zur Anwendung im Mund. 7-2009. Dostupné z: http://www.pharmazeutische-zeitung.de/fileadmin/nrf/pdf/1-Lidocain_Mund.pdf (15. 8. 2011).




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.